Publications (35)

2023

  1. Development of a telematic pharmaceutical care app (Haemoassist) for multidisciplinary follow-up of patients with congenital coagulopathies

    Expert Review of Hematology, Vol. 16, Núm. 3, pp. 213-226

2022

  1. Influence of statin treatment in a cohort of patients admitted for COVID-19

    Medicina Clinica, Vol. 158, Núm. 12, pp. 586-595

2021

  1. Real-world experience of palbociclib and ribociclib: novel oral therapy in metastatic breast cancer

    International Journal of Clinical Pharmacy, Vol. 43, Núm. 4, pp. 893-899

  2. Real-World Experience with Two-Drug Regimens in HIV-1-Infected Patients beyond the Indication of Clinical Trials: 48 Weeks' Results

    AIDS Research and Human Retroviruses, Vol. 37, Núm. 10, pp. 761-767

2019

  1. Defibrotide for the treatment of severe hepatic sinusoidal obstruction syndrome: A single-centre experience

    European Journal of Hospital Pharmacy , Vol. 26, Núm. 6, pp. 343-346

2017

  1. Perception survey on the value of the hospital pharmacist at the emergency department

    Farmacia Hospitalaria, Vol. 41, Núm. 3, pp. 357-370

2016

  1. Objective quantification of adherence to prophylaxis in haemophilia patients aged 12 to 25 years and its potential association with bleeding episodes

    Thrombosis Research, Vol. 143, pp. 22-27

  2. Juego de patentes. Sobre medicamentos genéricos y biosimilares

    Revista de calidad asistencial, Vol. 31, Núm. 2, pp. 99-105

  3. Analysis of an electronic medication reconciliation and information at discharge programme for frail elderly patients

    International Journal of Clinical Pharmacy, Vol. 38, Núm. 4, pp. 996-1001

2015

  1. Trazabilidad en el proceso farmacoterapéutico oncológico

    El Farmacéutico. Hospitales, Núm. 205, pp. 15-24

  2. Spanish Rheumatology Society and Hospital Pharmacy Society Consensus on recommendations for biologics optimization in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis

    Rheumatology (United Kingdom), Vol. 54, Núm. 7, pp. 1200-1209

2014

  1. Pharmacotherapy management in patients with potassium disorders

    Atencion Farmaceutica, Vol. 16, Núm. 1, pp. 62-68

  2. Adequacy of clotting factor in haemophilic patients underwent surgery based on analytical parameters and plasmatic clearance

    Atencion Farmaceutica, Vol. 16, Núm. 2, pp. 110-116

2013

  1. Trastuzumab induced cardiotoxicity in patients with HER2+ breast cancer

    Atencion Farmaceutica, Vol. 15, Núm. 4, pp. 261-267

  2. The use of C1 esterase inhibitor in long term prophylaxis of recurrent acute hereditary angioedema exacerbated by tamoxifen

    Atencion Farmaceutica, Vol. 15, Núm. 2, pp. 124-127

  3. Optimization use of stimulating factors of erythropoiesis

    Atencion Farmaceutica, Vol. 15, Núm. 5, pp. 321-328

  4. Lipid profile disorder in HIV infected patients treated with lopinavir/ritonavir and its relation with adherence To treatment

    Atencion Farmaceutica, Vol. 15, Núm. 3, pp. 171-177

  5. Incatibant acetate treatment of angioedema induced by ACE inhibitors (Angiotensin-Conversion Enzyme inhibitors)

    Atencion Farmaceutica, Vol. 15, Núm. 1, pp. 52-54

2012

  1. Análisis y repercusión clínica de los problemas relacionados con la terapia anticoagulante oral con antagonistas de la vitamina k

    Atención Farmacéutica, Vol. 14, Núm. 2, pp. 94-99

  2. Análisis y repercusión clínica de los problemas relacionados con la terapia anticoagulante oral con antagonistas de la vitamina K

    Atencion Farmaceutica, Vol. 14, Núm. 2, pp. 94-99